Japan Lifeline Co., Ltd. Stock

Equities

7575

JP3754500001

Medical Equipment, Supplies & Distribution

Delayed Japan Exchange 10:30:00 2024-07-04 pm EDT 5-day change 1st Jan Change
1,153 JPY 0.00% Intraday chart for Japan Lifeline Co., Ltd. +1.77% -8.71%
Sales 2025 * 53.88B 334M Sales 2026 * 56.41B 350M Capitalization 86.39B 536M
Net income 2025 * 8.07B 50.05M Net income 2026 * 8.59B 53.26M EV / Sales 2025 * 1.43 x
Net cash position 2025 * 9.58B 59.4M Net cash position 2026 * 18.91B 117M EV / Sales 2026 * 1.2 x
P/E ratio 2025 *
10.1 x
P/E ratio 2026 *
9.84 x
Employees 1,216
Yield 2025 *
3.99%
Yield 2026 *
4.03%
Free-Float 74.78%
More Fundamentals * Assessed data
Dynamic Chart
Japan Lifeline Completes 5.23 Billion Yen Share Acquisition via Tender Offer MT
Tranche Update on Japan Lifeline Co., Ltd.'s Equity Buyback Plan announced on May 1, 2024. CI
Japan Lifeline Co., Ltd.'s Equity Buyback announced on May 1, 2024 has closed with 5,000,100 shares, representing 6.67% for ¥5,225.1 million. CI
Japan Lifeline Co., Ltd. Announces Executive Changes CI
Japan Lifeline Co., Ltd. Proposes Dividend for the Fiscal Year Ended March 31, 2024 CI
Japan Lifeline's Attributable Profit Grows 9% in Fiscal Year Ended March MT
Japan Lifeline to Launch Tender Offer for Treasury Shares MT
Japan Lifeline to Dispose of 183 Million Yen Treasury Shares as Restricted Stock Compensation MT
Japan Lifeline Co., Ltd. Provides Consolidated and Non-Consolidated Earnings Guidance for the Second Quarter End and Year Ending March 31, 2025 CI
Japan Lifeline Co., Ltd. Announces Year-End Cash Dividend for the Year Ended March 31, 2024, Payable on June 27, 2024; Provides Year-End Cash Dividend Guidance for the Fiscal Year Ending March 31, 2025 CI
Japan Lifeline Co., Ltd. announces an Equity Buyback for 5,500,100 shares, representing 7.34% for ¥5,747.6 million. CI
Japan Lifeline Co., Ltd. authorizes a Buyback Plan. CI
Japan Lifeline Completes Cancellation of 7.16 Million Shares MT
Tranche Update on Japan Lifeline Co., Ltd.'s Equity Buyback Plan announced on May 10, 2023. CI
Japan Lifeline Co., Ltd.'s Equity Buyback announced on May 10, 2023, has closed with 3,000,000 shares, representing 3.9% for ¥3,319.77 million. CI
More news
1 day+0.96%
1 week+0.44%
Current month+1.77%
1 month+2.22%
3 months-0.77%
6 months-8.27%
Current year-8.71%
More quotes
1 week
1 133.00
Extreme 1133
1 164.00
1 month
1 058.00
Extreme 1058
1 164.00
Current year
1 058.00
Extreme 1058
1 357.00
1 year
956.00
Extreme 956
1 357.00
3 years
880.00
Extreme 880
1 418.00
5 years
880.00
Extreme 880
1 974.00
10 years
93.13
Extreme 93.125
3 780.00
More quotes
Managers TitleAgeSince
Founder 70 81-02-05
Chief Administrative Officer 62 92-03-31
Chief Operating Officer 66 84-08-31
Members of the board TitleAgeSince
Founder 70 81-02-05
Chief Operating Officer 66 84-08-31
Director/Board Member 52 98-04-30
More insiders
Date Price Change Volume
24-07-04 1,153 0.00% 20 200
24-07-04 1,153 +0.96% 94,700
24-07-03 1,142 -0.95% 123,700
24-07-02 1,153 +0.52% 176,100
24-07-01 1,147 +1.24% 168,200

Delayed Quote Japan Exchange, July 04, 2024 at 02:00 am EDT

More quotes
Japan Lifeline Co., Ltd. is a Japan-based company mainly engaged in the import, manufacture and sale of cardiac circulators and other medical devices. The Company is mainly engaged in the production of rhythm devices, electrophysiological (EP) and ablations, surgical products and intervention products. The rhythm devices include cardiac pacemakers, implantable cardioverter defibrillator (ICD), cardiac resynchronization therapy defibrillator (CRT-D) and other rhythm devices. The EP and ablations include EP catheters for cardiac arrhythmia examination, ablation catheters for arrhythmia treatment and other EP and ablations. The surgical products include prosthetic heart valves and annuloplasty rings for heart disease surgical treatment, vascular grafts, open stent grafts and stent grafts for aortic disease treatment, as well as other surgical products. The intervention products include balloon catheters, guide wires, penetration catheters and other intervention products.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
4
Last Close Price
1,153 JPY
Average target price
1,369 JPY
Spread / Average Target
+18.71%
Consensus